Table 2.
Multiplication ability of sRNA over expression strains in J774A.1 macrophages.
| sRNA Name | 1 h CFU | Over-expression strain/WT(1 h) | 48 h CFU | Over-expression strain/WT(48 h) | sRNA Name | 1 h CFU | Over-expression strain/WT(1 h) | 48 h CFU | Over-expression strain/WT (48 h) |
|---|---|---|---|---|---|---|---|---|---|
| BAS I 74 | 1.98E + 03 | 33.51% | 9.17E + 03 | 0.61% | BAS I 306 | 8.42E + 02 | 14.23% | 4.98E + 05 | 33.40% |
| BAS I 22 | 9.67E + 02 | 16.34% | 4.05E + 05 | 27.14% | BAS I 344 | 8.66E + 03 | 146.32% | 8.61E + 05 | 57.70% |
| BAS I 23 | 8.33E + 02 | 14.08% | 2.45E + 05 | 16.42% | BAS I 345 | 8.42E + 02 | 14.23% | 2.28E + 05 | 15.30% |
| BAS I 35 | 1.28E + 03 | 21.55% | 1.23E + 05 | 8.27% | BAS I 365 | 2.24E + 03 | 37.89% | 4.16E + 05 | 27.87% |
| BAS I 62 | 2.71E + 03 | 45.77% | 2.62E + 05 | 17.54% | BAS I 371 | 9.33E + 02 | 15.77% | 5.83E + 05 | 39.04% |
| BAS I 9 | 8.33E+02 | 14.08% | 7.52E + 05 | 50.38% | BAS I 387 | 5.42E + 03 | 91.55% | 1.02E + 06 | 68.16% |
| BAS I 84 | 2.80E + 03 | 47.32% | 4.33E + 05 | 29.04% | BAS II 5 | 2.01E + 03 | 33.94% | 3.66E + 05 | 24.52% |
| BAS I 122 | 1.10E + 03 | 18.59% | 1.15E + 06 | 77.08% | BAS II 36 | 8.42E + 02 | 14.23% | 3.18E + 05 | 21.34% |
| BAS I 130 | 8.67E + 03 | 146.48% | 1.10E + 06 | 73.39% | BAS II 37 | 1.15E + 03 | 19.44% | 6.55E + 05 | 43.90% |
| BAS I 133 | 1.63E + 03 | 27.46% | 5.52E + 05 | 36.97% | BAS II 39 | 1.57E + 03 | 26.48% | 3.68E + 05 | 24.69% |
| BAS I 137 | 3.11E + 03 | 52.53% | 8.50E + 05 | 56.97% | BAS II 47 | 1.99E + 03 | 33.67% | 4.15E + 05 | 27.81% |
| BAS I 151 | 1.91E + 03 | 32.25% | 7.80E + 05 | 52.28% | BAS II 73 | 9.08E + 02 | 15.35% | 3.22E + 05 | 21.56% |
| BAS I 176 | 2.28E + 03 | 38.45% | 2.84E + 05 | 19.05% | BAS II 74 | 1.15E + 03 | 19.49% | 6.33E + 05 | 42.45% |
| BAS I 193 | 1.49E + 03 | 25.22% | 5.88E + 05 | 39.43% | BAS II 99 | 1.60E + 03 | 27.04% | 3.33E + 05 | 22.34% |
| BAS I 214 | 2.31E+03 | 39.01% | 5.47E + 05 | 36.64% | BAS II 117 | 5.42E + 03 | 91.55% | 6.23E + 05 | 41.78% |
| BAS I 218 | 1.79E + 03 | 30.29% | 5.58E + 05 | 37.42% | BAS II 133 | 3.27E + 03 | 55.21% | 9.51E + 05 | 63.73% |
| BAS I 221 | 8.33E + 03 | 140.83% | 1.25E + 06 | 83.44% | BAS II 149 | 1.50E + 03 | 25.35% | 4.96E + 05 | 33.23% |
| BAS I 228 | 1.81E + 03 | 30.56% | 1.00E + 06 | 67.02% | BAS II 152 | 2.90E + 03 | 49.01% | 8.02E + 05 | 53.73% |
| BAS I 244 | 5.50E + 03 | 92.95% | 9.47E + 05 | 63.45% | BAS II 150 | 1.50E + 03 | 25.35% | 4.96E + 05 | 33.23% |
| BAS I 245 | 1.03E + 03 | 17.46% | 8.27E + 05 | 55.41% | 2308-pBBR1 | 2.14E + 03 | 36.20% | 1.00E + 06 | 67.09% |
| BAS I 262 | 9.25E + 02 | 15.63% | 3.97E + 05 | 26.59% | 2308 | 5.92E + 03 | 100.00% | 1.49E + 06 | 100.00% |
| BAS I 273 | 8.42E + 02 | 14.23% | 3.95E + 05 | 26.47% | |||||
| BAS I 283 | 7.08E + 03 | 119.71% | 5.17E + 05 | 34.63% | |||||
| BAS I 304 | 1.28E + 03 | 21.68% | 4.19E + 05 | 28.09% |